Rebecca Wissner

Title: Innovations of Rebecca Wissner in Biotech

Introduction

Rebecca Wissner is an esteemed inventor based in Philadelphia, PA, who has made significant contributions to the field of biotechnology. With her extensive research background and innovative mindset, she has obtained one patent that highlights her expertise in antibody engineering.

Latest Patents

Rebecca is the inventor of a patent titled "Site-specific conjugation of glycosylated monoclonal antibodies with transglutaminase." This innovative work describes engineered antibodies that are useful for precise conjugation by transglutaminase. The patent also outlines methods for site-specific conjugation, details about the site-specifically conjugated antibodies, and their pharmaceutical compositions and uses. This advancement has the potential to enhance therapeutic applications in medicine.

Career Highlights

Rebecca is currently employed at Janssen Biotech, Inc., a leading company in the biotechnology industry. Her role involves working on cutting-edge research and development of biopharmaceutical products. With a strong foundation in her field, she has positioned herself as a prominent figure in innovative antibody research.

Collaborations

In her professional journey, Rebecca has collaborated with notable colleagues, including Vadim Dudkin. Together, they have engaged in innovative research projects, pushing the boundaries of what is possible in biotechnology. Their joint efforts contribute to the ongoing evolution of antibody-related therapies.

Conclusion

Rebecca Wissner exemplifies the spirit of innovation in biotechnology. Her groundbreaking patent on site-specific conjugation of glycosylated monoclonal antibodies underscores her commitment to advancing medical science. With her current work at Janssen Biotech, Inc. and fruitful collaborations, she continues to drive progress in the field.